Solasto Corporation
6197・Prime Market・Services
Medical Business
The Group's largest segment, providing outsourced medical administrative services and staffing to medical institutions
| Period | Current | Previous | Change |
|---|---|---|---|
| Net sales (FY2025 full year) | ¥73,834 million | ¥71,214 million | ↑ |
| Operating profit (FY2025 full year) | ¥4,173 million | ¥4,388 million | ↓ |
| Operating margin (FY2025 full year) | 5.7% | 6.2% | ↓ |
| Medical outsourcing net sales (FY2025 full year) | ¥65,666 million | ¥63,013 million | ↑ |
| Medical staffing net sales (FY2025 full year) | ¥6,305 million | ¥6,634 million | ↓ |
| Segment assets (end of FY2025) | ¥10,773 million | ¥10,451 million | ↑ |
Business Details
Provides medical administrative services such as reception, billing, and medical fee claims, medical office peripheral services such as physician clerical assistance and nursing assistance, and hospital management support services such as hospital management consulting and IT services to medical institutions nationwide, through outsourcing and staffing arrangements. From FY2025, the Smart Hospital Business has been integrated into this segment. This is the Group's largest segment, accounting for approximately 52.3% of consolidated net sales.
Recent Overview
Net sales increased on the effect of price revisions, but operating profit declined due to strengthened treatment improvement and IT investments
In FY2025, net sales in the Medical Business increased 3.7% year on year to ¥73,834 million, driven by progress in price revision negotiations for existing outsourced operations exceeding the prior year. Operating profit, however, decreased 4.9% year on year to ¥4,173 million (operating margin of 5.7%), despite the price revision effect exceeding that of the prior year, due to increased investment in employee skills development and treatment improvement as well as new IT investments. From FY2025, the Smart Hospital Business has been integrated into this segment.
Key Products
Growth Drivers
- Continued progress in price revision negotiations for existing outsourced operations (progress in FY2025 exceeded the prior year)
- Stable trend in demand for outsourcing of medical administrative work among medical institutions, primarily hospitals
- Business synergies from integrating the Smart Hospital Business into the Medical Business segment
- Productivity improvements and reductions in SG&A expenses through transition to next-generation operations
- Promotion of next-generation outsourcing business development and evolution of the solutions business under the medium-term management plan
Risks
- Increased costs from the strategic strengthening of investment in employee treatment improvement and human resource development (operating margin declined to 5.7% in FY2025)
- Short-term increase in cost burden from new IT investments (including renewal of next-generation IT infrastructure)
- Difficulty in timely and appropriate hiring of personnel in the medical administrative and hospital management fields (a key challenge across the industry)
- Declining trend in medical staffing net sales (¥6,305 million in FY2025, down 5.0% year on year)
- Non-disclosure of next-period earnings forecasts due to the planned delisting associated with the MBO, reducing transparency of the medium- to long-term business plan
Last updated: June 23, 2026

